查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1459776

生物製药发酵系统市场 - 全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

Biopharmaceutical Fermentation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 254 Pages | 商品交期: 2-10个工作天内

价格

生物製药发酵系统市场 - 报告范围

TMR 关于全球生物製药发酵系统市场的报告研究了过去和当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球生物製药发酵系统的收入2017- 2031年期间的市场，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球生物製药发酵系统市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解生物製药发酵系统市场。

市场概况
2022年市场价​​值 234 亿美元
2031 年市场价值 526 亿美元
CAGR 9.5%

该报告深入研究了全球生物製药发酵系统市场的竞争格局。全球生物製药发酵系统市场的主要参与者已经确定，并且每个参与者都根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球生物製药发酵系统市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依产品分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按产品，2017-2031
    • 上游产品
      • 发酵槽
      • 生物过程分析仪
      • 製程监控设备
      • 文化与媒体准备
      • 培养基以及缓衝剂和诱导剂
      • 其他上游产品
    • 下游产品
      • 过滤和分离系统
      • 色谱法
      • 耗材及配件
      • 其他下游产品
  • 市场吸引力分析：按产品

第 7 章：全球市场分析与预测：按应用分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依应用分类，2017-2031
    • 重组蛋白
    • 单株抗体
    • 抗生素
    • 益生菌
    • 其他的
  • 市场吸引力分析：按应用

第 8 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 生物製药公司
    • 合约製造组织
    • 合约研究组织
    • 学术研究机构
    • 食品工业
    • 其他的
  • 市场吸引力分析：按最终用户

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • GE Healthcare
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Sartorius Stedim Biotech
    • F. Hoffman-La Roche Ltd.
    • Eppendorf AG
    • Merck KGaA
    • Nova Biomedical
    • Lonza Group AG
    • BD
Product Code: TMRGL46989

Biopharmaceutical Fermentation Systems Market - Scope of Report

TMR's report on the global biopharmaceutical fermentation systems market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global biopharmaceutical fermentation systems market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global biopharmaceutical fermentation systems market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the biopharmaceutical fermentation systems market.

Market Snapshot
Market Value in 2022US$ 23.4 Bn
Market Value in 2031US$ 52.6 Bn
CAGR9.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global biopharmaceutical fermentation systems market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global biopharmaceutical fermentation systems market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global biopharmaceutical fermentation systems market.

The report delves into the competitive landscape of the global biopharmaceutical fermentation systems market. Key players operating in the global biopharmaceutical fermentation systems market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global biopharmaceutical fermentation systems market profiled in this report.

Key Questions Answered in Global biopharmaceutical fermentation systems Market Report:

  • What is the sales/revenue generated by biopharmaceutical fermentation systems across all regions during the forecast period?
  • What are the opportunities in the global biopharmaceutical fermentation systems market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Biopharmaceutical Fermentation Systems Market - Research Objectives and Research Approach

The comprehensive report on the global biopharmaceutical fermentation systems market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global biopharmaceutical fermentation systems market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global biopharmaceutical fermentation systems market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Biopharmaceutical Fermentation Systems Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Upstream Products
      • 6.3.1.1. Fermenters
      • 6.3.1.2. Bioprocess Analyzers
      • 6.3.1.3. Process Monitoring Devices
      • 6.3.1.4. Culture & Media Preparation
      • 6.3.1.5. Culture Media and Buffers & Inducers
      • 6.3.1.6. Other Upstream Products
    • 6.3.2. Downstream Products
      • 6.3.2.1. Filtration & Separation Systems
      • 6.3.2.2. Chromatography
      • 6.3.2.3. Consumables & Accessories
      • 6.3.2.4. Other Downstream Products
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Recombinant Proteins
    • 7.3.2. Monoclonal Antibodies
    • 7.3.3. Antibiotics
    • 7.3.4. Probiotics
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Biopharmaceutical Companies
    • 8.3.2. Contract Manufacturing Organizations
    • 8.3.3. Contract Research Organizations
    • 8.3.4. Academic Research Institutes
    • 8.3.5. Food Industry
    • 8.3.6. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Product, 2017-2031
    • 10.3.1. Upstream Products
      • 10.3.1.1. Fermenters
      • 10.3.1.2. Bioprocess Analyzers
      • 10.3.1.3. Process Monitoring Devices
      • 10.3.1.4. Culture & Media Preparation
      • 10.3.1.5. Culture Media and Buffers & Inducers
      • 10.3.1.6. Other Upstream Products
    • 10.3.2. Downstream Products
      • 10.3.2.1. Filtration & Separation Systems
      • 10.3.2.2. Chromatography
      • 10.3.2.3. Consumables & Accessories
      • 10.3.2.4. Other Downstream Products
  • 10.4. Market Value Forecast, by Application, 2017-2031
    • 10.4.1. Recombinant Proteins
    • 10.4.2. Monoclonal Antibodies
    • 10.4.3. Antibiotics
    • 10.4.4. Probiotics
    • 10.4.5. Others
  • 10.5. Market Value Forecast, by End-user, 2017-2031
    • 10.5.1. Biopharmaceutical Companies
    • 10.5.2. Contract Manufacturing Organizations
    • 10.5.3. Contract Research Organizations
    • 10.5.4. Academic Research Institutes
    • 10.5.5. Food Industry
    • 10.5.6. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Product
    • 10.7.2. By Application
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Product, 2017-2031
    • 11.3.1. Upstream Products
      • 11.3.1.1. Fermenters
      • 11.3.1.2. Bioprocess Analyzers
      • 11.3.1.3. Process Monitoring Devices
      • 11.3.1.4. Culture & Media Preparation
      • 11.3.1.5. Culture Media and Buffers & Inducers
      • 11.3.1.6. Other Upstream Products
    • 11.3.2. Downstream Products
      • 11.3.2.1. Filtration & Separation Systems
      • 11.3.2.2. Chromatography
      • 11.3.2.3. Consumables & Accessories
      • 11.3.2.4. Other Downstream Products
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Recombinant Proteins
    • 11.4.2. Monoclonal Antibodies
    • 11.4.3. Antibiotics
    • 11.4.4. Probiotics
    • 11.4.5. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Biopharmaceutical Companies
    • 11.5.2. Contract Manufacturing Organizations
    • 11.5.3. Contract Research Organizations
    • 11.5.4. Academic Research Institutes
    • 11.5.5. Food Industry
    • 11.5.6. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By Application
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Product, 2017-2031
    • 12.3.1. Upstream Products
      • 12.3.1.1. Fermenters
      • 12.3.1.2. Bioprocess Analyzers
      • 12.3.1.3. Process Monitoring Devices
      • 12.3.1.4. Culture & Media Preparation
      • 12.3.1.5. Culture Media and Buffers & Inducers
      • 12.3.1.6. Other Upstream Products
    • 12.3.2. Downstream Products
      • 12.3.2.1. Filtration & Separation Systems
      • 12.3.2.2. Chromatography
      • 12.3.2.3. Consumables & Accessories
      • 12.3.2.4. Other Downstream Products
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Recombinant Proteins
    • 12.4.2. Monoclonal Antibodies
    • 12.4.3. Antibiotics
    • 12.4.4. Probiotics
    • 12.4.5. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Biopharmaceutical Companies
    • 12.5.2. Contract Manufacturing Organizations
    • 12.5.3. Contract Research Organizations
    • 12.5.4. Academic Research Institutes
    • 12.5.5. Food Industry
    • 12.5.6. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product
    • 12.7.2. By Application
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Product, 2017-2031
    • 13.3.1. Upstream Products
      • 13.3.1.1. Fermenters
      • 13.3.1.2. Bioprocess Analyzers
      • 13.3.1.3. Process Monitoring Devices
      • 13.3.1.4. Culture & Media Preparation
      • 13.3.1.5. Culture Media and Buffers & Inducers
      • 13.3.1.6. Other Upstream Products
    • 13.3.2. Downstream Products
      • 13.3.2.1. Filtration & Separation Systems
      • 13.3.2.2. Chromatography
      • 13.3.2.3. Consumables & Accessories
      • 13.3.2.4. Other Downstream Products
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Recombinant Proteins
    • 13.4.2. Monoclonal Antibodies
    • 13.4.3. Antibiotics
    • 13.4.4. Probiotics
    • 13.4.5. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Biopharmaceutical Companies
    • 13.5.2. Contract Manufacturing Organizations
    • 13.5.3. Contract Research Organizations
    • 13.5.4. Academic Research Institutes
    • 13.5.5. Food Industry
    • 13.5.6. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product
    • 13.7.2. By Application
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Product, 2017-2031
    • 14.3.1. Upstream Products
      • 14.3.1.1. Fermenters
      • 14.3.1.2. Bioprocess Analyzers
      • 14.3.1.3. Process Monitoring Devices
      • 14.3.1.4. Culture & Media Preparation
      • 14.3.1.5. Culture Media and Buffers & Inducers
      • 14.3.1.6. Other Upstream Products
    • 14.3.2. Downstream Products
      • 14.3.2.1. Filtration & Separation Systems
      • 14.3.2.2. Chromatography
      • 14.3.2.3. Consumables & Accessories
      • 14.3.2.4. Other Downstream Products
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Recombinant Proteins
    • 14.4.2. Monoclonal Antibodies
    • 14.4.3. Antibiotics
    • 14.4.4. Probiotics
    • 14.4.5. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Biopharmaceutical Companies
    • 14.5.2. Contract Manufacturing Organizations
    • 14.5.3. Contract Research Organizations
    • 14.5.4. Academic Research Institutes
    • 14.5.5. Food Industry
    • 14.5.6. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product
    • 14.7.2. By Application
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. GE Healthcare
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Thermo Fisher Scientific Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Danaher Corporation
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Sartorius Stedim Biotech
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. F. Hoffman-La Roche Ltd.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Eppendorf AG
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Merck KGaA
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Nova Biomedical
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Lonza Group AG
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. BD
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 07: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 11: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 15: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 19: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn), by Product, 2022
  • Figure 03: Global Biopharmaceutical Fermentation Systems Market Value Share, by Product, 2022
  • Figure 04: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn), by Application, 2022
  • Figure 05: Global Biopharmaceutical Fermentation Systems Market Value Share, by Application, 2022
  • Figure 06: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn), by End-user, 2022
  • Figure 07: Global Biopharmaceutical Fermentation Systems Market Value Share, by End-user, 2022
  • Figure 08: Global Biopharmaceutical Fermentation Systems Market Value Share, by Region, 2022
  • Figure 09: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 10: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022-2031
  • Figure 11: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 12: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022-2031
  • Figure 13: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 14: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022-2031
  • Figure 15: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 16: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Region, 2022-2031
  • Figure 17: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 18: North America Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 19: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 20: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country, 2022-2031
  • Figure 21: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022-2031
  • Figure 22: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022-2031
  • Figure 23: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022-2031
  • Figure 24: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 25: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 26: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Europe Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 28: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 30: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022-2031
  • Figure 31: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022-2031
  • Figure 32: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022-2031
  • Figure 33: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 34: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 35: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 36: Asia Pacific Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 37: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 39: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022-2031
  • Figure 40: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022-2031
  • Figure 41: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022-2031
  • Figure 42: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 43: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 44: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 45: Latin America Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 46: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 48: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022-2031
  • Figure 49: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022-2031
  • Figure 50: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022-2031
  • Figure 51: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 52: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 53: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 54: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 55: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 57: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022-2031
  • Figure 58: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022-2031
  • Figure 59: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022-2031
  • Figure 60: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 61: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 62: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023-2031